Team

Our people

Krystal employees are our most valuable resource for continued success.

Adam Tarabay
Adam Tarabay - Materials Coordinator

Adam Tarabay is a materials coordinator for Krystal Biotech, focusing heavily on the GMP materials. He is a graduate of Robert Morris University where he earned a Bachelor’s of Science in Business Administration with a Business Management / Hospitality & Tourism focus. He is born and raised in Pittsburgh and has a wide spread of knowledge in various industries over his professional career; supply chain, convention services, logistics, resource/inventory management, restaurant management, and warehousing. Adam is a contagiously positive person and is very excited about his opportunity with Krystal. Adam loves Pittsburgh sports, college football, and listening to country music.

Adam Tarabay
Materials Coordinator

Akshata Patil - Regulatory Affairs Associate
Akshata Patil is a Regulatory Affairs Associate at Krystal. She is a recent graduate from the Northeastern University's Regulatory Affairs Program at Boston. She has completed internships at Sen-Jam Pharmaceuticals and Voyager Therapeutics. Prior to this, Akshata has received her B.S. in Drug Chemistry, M.S in Nutraceuticals from the University of Mumbai at India. Outside of work, Akshata loves to read novels and try out new recipes.

Akshata Patil
Regulatory Affairs Associate

Ayush Mukherjee
Ayush Mukherjee - Quality Assurance Associate
Ayush Mukherjee joined the Krystal Team as a Quality Assurance Associate. Prior to joining Krystal, he worked in the Quality department at Catalent Pharma Solutions. Ayush has a Master's degree in Materials Science and Engineering from Pennsylvania State University and completed his bachelor's degree in Polymer Science from Delhi College of Engineering. Outside of work he loves playing soccer, meeting new people, travelling, and long drives.

Ayush Mukherjee
Quality Assurance Associate

Ben Worek
Ben Worek - Manufacturing Tech Services
Ben Worek has joined the Krystal team as a Manufacturing Associate Level II. Previously, Ben worked at Cook Myosite where he assisted with cell therapy manufacturing in their Production department. Ben attended Clarion University of Pennsylvania where he obtained a Bachelor of Science in Biology in 2017. Currently, Ben is working to obtain a Master of Science, with a focus on regulatory affairs, through the University of Maryland University College. With a few years of GMP experience, Ben looks to bring a fresh outlook and cell culturing experience to the Krystal team. In his free time, you can find Ben playing soccer or watching his favorite team, Manchester United, play. If he is not on the soccer field, he’s most likely at Chipotle.

Ben Worek
Manufacturing Tech Services

Binoy Kapadia
Binoy Kapadia - Clinical Research Associate
Binoy Kapadia is an engaging and hardworking individual who will be supporting the Clinical Operations team at Krystal Biotech. Prior to joining Krystal, Binoy worked in a hybrid Medical Science Liaison/Clinical Research Associate role at DAVA Oncology and attended medical school at Campbell University. Binoy received his B.S. in Biology and B.A. in Chemistry from the University of North Carolina at Chapel Hill. Outside of work, Binoy loves to cook, hike, and learn more about technology.

Binoy Kapadia
Clinical Research Associate

Boeun Lee - Senior Research Associate
Boeun Lee is a biologist with over 10 years of experience in biomedical tissue engineering. Prior to joining Krystal Biotech, she was involved in developing new orthopedic biomaterials at University of Pittsburgh. She received her M.S in Biology at Chung-Ang university in South Korea. At Krystal, she supports upstream process development. In her free time, she enjoys playing instruments, watching movies and traveling.

Boeun Lee
Senior Research Associate

Brandi Skinner - Senior Quality Control Specialist
Brandi has joined Krystal Biotech as a Quality Control Specialist and has over 10 years of experience working in the biotech industry. Previously, she worked in a quality control department that was regulated by CLIA and NYSDOH. Brandi earned a degree in Biology with a concentration in Microbiology and Immunology from Virginia Tech and is currently completing a degree in Information Science and Technology from Penn State. In her free time, Brandi loves to watch hockey and football and enjoys reading.

Brandi Skinner
Senior Quality Control Specialist

Brittani Agostini
Brittani Agostini - Clinical Operations Manager
Brittani Agostini has a passion for research and has been immersed in research for 10 years. She has a background in cellular and animal model protocols while working in the PACCM division at the University of Pittsburgh, as well as clinical trials with a focus on orphan drug studies for Cystic Fibrosis. Brittani holds a B.A from Washington and Jefferson College and a B.S.N from the University of Pittsburgh. Brittani has spent time working in the Neonatal ICU at UPMC-Children’s Hospital of Pittsburgh. Prior to her position at Krystal, Brittani held a position as a University of Pittsburgh IRB committee member, Therapeutics Development Network protocol review committee member and also was a UPMC-Children’s Hospital of Pittsburgh Ethics Committee member. In her free time she enjoys yoga, mountain biking, participating in duathlons and running team relays.

Brittani Agostini
Clinical Operations Manager

Carey Cole
Carey Cole – Materials Coordinator
Carey Cole serves in the role of Materials Coordinator with Krystal.  Prior to joining Krystal, Carey worked in a Facilities Maintenance type of role within the Cell tower industry.  Before that Carey was in the manufacturing field for a number of years and worked for Matthews International, and Wabtec.  In both of these roles Carey, was responsible for Production Planning and Inventory Control.  Outside of work, Carey volunteers with his local fire department and holds the position of Chief.  He also likes to spend time with his family and goes camping regularly.

Carey Cole
Materials Coordinator

Carl Clinger – Senior Director, Quality Assurance
Carl Clinger is the Director of Quality Assurance at Krystal Biotech, with over 10 years of experience in the petrochemical industry in varying roles including process engineer, environmental manager, production manager and senior project engineer. He then moved to pharmaceuticals where he headed the Equipment and Facility validation, Metrology, Environmental Microbiology, Cleaning Validation, and Computer Validation departments for a 19 billion dosage unit OSD plant (the world’s largest OSD facility under one roof). Carl joined the Krystal Biotech team as Quality Assurance Specialist. Prior to his experience in the petrochemical and pharmaceuticals industry, Carl built and ran the first commercial brewery in the state of West Virginia since prohibition. Outside of work, Carl spends his time on his farm raising meat goats and alpacas and is working to restore the original log cabin on the property built in 1865.

Carl Clinger
Senior Director, Quality Assurance

Carrie Miller – Director, Quality Control
Carrie Miller has worked in the Pittsburgh Biopharmaceutical industry for 15+ years.  She has a strong background in multiple disciplines of drug development and manufacture including assay development, quality program management, cGMP manufacture, and facilities management.  She recently served as the Director of Analytics and Quality at Western Oncolytics. During her tenure at Western she built and managed the Quality Control Department, led tech transfer to CMO for virus and cell manufacture and oversaw the construction of the company’s new facility.  Carrie has two amazing sons, Jack (8) and Tucker (5), who keep her quite busy and exhausted.

Carrie Miller
Director, Quality Control

Cathy Trumpower - Senior Director, GMP Manufacturing
Cathy Trumpower has worked in the applied biologics field for over 25 years. She spent the first half of her career at University of Pittsburgh Cancer Institute in the Cell and Gene Therapy department preparing cell-based treatments for patients in clinical trials. Cathy then moved on to a career in the biotechnology industry working with a protein-based product, translating a laboratory process into GMP manufacturing, including facility operations and ensuring QA and regulatory compliance of the process. Cathy is a Pittsburgh proud native excited to be involved in the expanding biotech industry in the local region. She enjoys spending time with her family, reading about history and singing in her church choir.

Cathy Trumpower
Senior Director, GMP Manufacturing

Cheaney Seiler - Research Associate, Analytical Sciences
Cheaney is a research associate in the analytical sciences department. He received his B.S. in Biology from Susquehanna University. Prior to joining the Krystal team, Cheaney worked as an associate geneticist, performing DNA extractions, PCR, and next-generation sequencing (NGS). In his free time, Cheaney enjoys hiking, playing guitar, and visiting breweries.

Cheaney Seiler
Research Associate, Analytical Sciences

Chris Mason - Board Member
Dr. Mason is a Founder and Chief Scientific Officer at AVROBIO, a clinical-stage, gene therapy company. He is a clinician-scientist with over 25 years of cell and gene therapy experience spanning research and development, clinical medicine, and bioprocessing. He is a Full Professor of Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London. In 2019, he was elected as a Fellow of The Academy of Medical Sciences. He is also a Founder and Non-Executive Director of OriBiotech, a company focused on next-generation fully-automated cell therapy bioprocessing. Dr. Mason was instrumental in the founding of the Alliance for Regenerative Medicine (ARM), the UK-Israel Science Council, and the London Regenerative Medicine Network. He is on the SAB of number of companies as well as the UK Cell & Gene Therapy Catapult and the Canadian Centre for the Commercialization of Regenerative Medicine (CCRM). Dr. Mason is Senior Editor of the journals, ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’.

Chris Mason
Board Member

Court Freedman - Senior Scientist
Court Freedman is a molecular biologist and biochemist with 10+ years of experience in genome modification and the biochemical characterization of proteins. He received his Ph.D. in Microbiology and Immunology at the Virginia Commonwealth University School of Medicine where he studied the molecular genetics and physiology of spirochetes. After a postdoc at the University of Pittsburgh, studying bacterial genetics and the cellular activity of bacterial toxins, Court joined the team at Krystal Biotech where he supports discovery and platform development. In his free time, Court enjoys embarking on culinary adventures at home and around town, cheering for his favorite sports teams, traveling, and reading postmodern fiction.

Court Freedman
Senior Scientist

Dan Janney - Board Member
Dan Janney is the Managing Partner of Alta Partners. Dan Janney joined Alta Partners at its founding in 1996. He has nearly 25 years of successful early-stage investing experience in life sciences. Dan’s focus on working with talented entrepreneurs to create companies around novel insights in biology and new approaches to drug discovery has led to the funding and development of 35 companies.  Prior to Alta, Dan was a senior investment banker at Montgomery Securities. Dan is currently on the board of directors of several public and private companies, including Allakos (NASDAQ:ALLK), Be Biopharma, Curasen Therapeutics, Esperion Therapeutics (NASDAQ:ESPR), Krystal Biotech (NASDAQ:KYRS), Lassen Therapeutics, Novome Biotechnologies, and Prolacta Bioscience. In addition, he led Alta’s investments in Astex Pharmaceuticals (acquired by Supergen), Cellective (acquired by Medimmune), ChemGenex (ASX:CXS acquired by Cephalon), CoTherix (NASDAQ:CTRX acquired by Actellion), Definity Health (acquired by United Health), Dynavax (NASDAQ:DVAX), Endonetics (acquired by Medtronic), Ilex Oncology (NASDAQ:ILXO acquired by Millennium Pharmaceuticals), InterMune (NASDAQ:ITMN acquired by Roche), LJL Biosystems (NASDAQ:LJLB acquired by Molecular Devices), Mako Surgical (NASDAQ:MAKO acquired by Stryker) and Triangle Pharmaceuticals (NASDAQ:VIRS acquired by Gilead). Dan is a member of The President’s Council of the J. David Gladstone Institutes and the vice chair of the Board of Directors of the California Academy of Sciences. He also serves on the Board of Regents of Georgetown University. He holds a B.A. from Georgetown University and a Master of Business Administration from the Anderson School at the University of California, Los Angeles.

Dan Janney
Board Member

David Reitsma - Facilities Manager
David is an experienced quality professional with a background in both laboratory and manufacturing systems. He has spent 12 years in the commercial environmental laboratory business and 15 years in the pharmaceutical industry where he gained expertise in GMP, GLP, and GCP. David is excited for the opportunity to apply this experience at Krystal by helping to develop and implement GMP compliant quality systems, laboratory space, and manufacturing facilities. David is an avid reader, a serious puck-head, and a certified coffee snob.

David Reitsma
Facilities Manager

Devnath Baragada - Research Associate, Downstream Process Development
Dev (Devnath) Baragada is a Downstream Process Development Research Associate. Prior to Joining Krystal, Dev was a contractor at Manufacturing Science Downstream at Bristol Myers Squibb and was a Co-op at Upstream Process Development at Regeneron Pharmaceuticals, Inc. Dev received M.S degree in Chemical Engineering from Purdue University. Outside of work, Dev plays cricket, basketball, plays guitar and loves to explore new places.

Devnath Baragada
Research Associate, Downstream Process Development

Dino A. Rossi - Board Member
Dino A. Rossi is a results oriented, hands-on senior executive with proven experience initiating and leading organizations through the chaos and ambiguity of change. Strengths in defining and building management teams to execute plans and build shareholder value. Excellent experience in international relationships, LBOÕs, directing operations, research and development and commercial groups. Special ability to motivate and manage employees and Board members with intuitive business understanding. Retired as Interim President of Elite Comfort Solutions (ECS) in January, 2017, after working with PE group, Arsenal Capital Partners, to form this $450M revenue technology leading polyurethane foam entity via 4 acquisitions in a 6-month period, beginning in January 2016. Successfully transitioned this role to a permanent CEO and is now Board Advisor to Arsenal / ECS. President and CEO of Balchem Corporation (BCPC-Nasdaq) from 1997 thru 2015, and Chairman of the Board of Directors from 2007 thru 2016. While at Balchem lead significant strategic changes and growth of the business ($28M to $550M in revenue) and increased Net Income driving the stock market capitalization from $20M to $1.8B, focused on specialty chemicals for human and animal health, nutritional supplements and certain industrial end markets. Rebuilt the management team, Board of Directors and executed 6 strategic acquisitions and improved technologies that positively altered the Balchem business direction. Wall Street Journal, January 2016, did an analysis and wrote an article on the best performing stock over the last 30 years and in fact it was Balchem , up 107,099% . Prior to this, Mr. Rossi was Chief Financial Officer and Treasurer from April 1996. He was Vice President, Finance and Administration of Norit Americas Inc., a wholly-owned subsidiary of Norit N.V., a Dutch chemicals company, from January 1994 to February 1996, and Vice President, Finance and Administration of Oakite Products Inc., a specialty chemicals company, from 1987 to 1993. This company was on the NYSE until acquired by PE group Carlyle. Mr. Rossi worked with Carlyle as the CFO until the company was sold to a large German conglomerate, Metalgeselschaft. Prior to this role Mr. Rossi worked for Diamond Shamrock progressing through various accounting and financial roles in NA and Canada.

Dino A. Rossi
Board Member

Erik Schneider
Erik Schneider - Process Validation Engineer
Erik Schneider is a process validation engineer with a background in process development. Erik holds a B.S. in Chemical Engineering from Penn State University. Prior to joining Krystal he spent 4 years at Regeneron Pharmaceuticals developing downstream unit operations for multiple antibody programs. Outside of work, Erik enjoys playing ultimate frisbee, hiking, and skiing.

Erik Schneider
Process Validation Engineer

Evan Snyder
Evan Snyder - Manufacturing Associate
Evan is a recent graduate of Penn State University and is part of the Manufacturing team at Krystal Biotech. During his time at Penn State, he completed internships at Philips Ultrasound and MilliporeSigma, where he was a member of continuous improvement teams. Outside of work, Evan likes to stay active and spend time with his friends and family.

Evan Snyder
Manufacturing Associate

George Chen
George Chen - IT and CSV Manager
George is an IT professional with over 20 years in life sciences industry. He has hands-on experience in multiple technology disciplines including IT strategy, vendor relationships, infrastructure management, technical support, ERP, Lab, Manufacturing and Quality systems as well as business intelligence and computerized system validation.  In his off time, George enjoys scripted reality shows, is a casual gamer and loves to travel.

George Chen
IT and CSV Manager

Gloria Feeney
Gloria Feeney - Clinical Trial Assistant
Gloria Feeney is a Clinical Trial Assistant. Prior to joining the team at Krystal Biotech, Gloria worked in project management for phase III and IV clinical trials at a local CRO. Gloria received a B.S. and a B.A. from the University of Pittsburgh at Greensburg. Outside of work, Gloria enjoys spending time with her family, visiting breweries and historical sites, and gathering with friends for game nights several times a week.

Gloria Feeney
Clinical Trial Assistant

Gloria (Bo) Lin - Accounting Manager
Gloria has 10+ years of accounting and tax experience including 2.5 years as a senior accountant and financial analyst in China and 8 years in a San Francisco based accounting firm. Prior to joining Krystal, Gloria worked as an accounting and tax manager whose clients included public and non-public companies in computer technology, financial service, biotech consulting, and healthcare industries. Gloria received her M.S. degree in Accountancy from Miami University in Oxford Ohio. She is a Certified Public Accountant in the state of California. Outside of work, Gloria enjoys cooking, gardening, and traveling.

Gloria (Bo) Lin
Accounting Manager

Hayley Eicher
Hayley Eicher - Manufacturing Associate
Hayley Eicher is recent graduate of Duquesne University with a degree in Biomedical Engineering. Prior to joining Krystal, Hayley was a Biomedical Engineer/Lab manager involved with Diabetes research for an early stage startup. Additionally, she has experience in biomechanics research and cell culture. Beyond work, Hayley enjoys cooking, baking, and attending hot yoga classes to burn off the calories.

Hayley Eicher
Manufacturing Associate

Hayley Lombardo - Quality Control Specialist
Hayley Lombardo joined Krystal Biotech as a Quality Control Specialist. Previously, she worked as a senior QC Analyst for Western Oncolytics and as a Radiobiologist for Charles River Laboratories. Hayley received her B.S. in Biological Sciences with a focus in Microbiology and a minor in Chemistry from Youngstown State University. Hayley enjoys 3D printing as a hobby, spending time with friends, and taking care of her dog, Mr. Miyagi.

Hayley Lombardo
Quality Control Specialist

Chris Naftzger
J. Christopher Naftzger - Chief Legal Officer and Corporate Secretary
Chris Naftzger joined Krystal Biotech as its Chief Legal Officer and Corporate Secretary in February 2020.  Prior to joining Krystal, he was Vice President, Deputy General Counsel and Assistant Secretary of Nabriva Therapeutics plc (NASDAQ: NBRV), where he was part of the team that transformed Nabriva from a clinical-stage to commercial-stage pharmaceutical company, with the launch of its lead product, XENLETATM, the first new systemic class of antibiotic approved in the U.S. in nearly two decades.  He also served as Vice President, General Counsel, Chief Compliance Officer, and Secretary of Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a developer and manufacturer of innovative drug delivery systems, where he was the company’s first general counsel and established the corporate legal and compliance functions following Unilife’s listing on NASDAQ.  Previously, Chris held senior in-house counsel positions with Chesapeake Corporation (NYSE: CSK) and Koch Industries.  After law school, Chris worked as a corporate associate at Dyer Ellis & Joseph, P.C. in Washington, DC, where he became a partner upon the firm’s merger with Blank Rome LLP.  Chris obtained his undergraduate degree from Hampden-Sydney College and his law degree from the Willamette University College of Law, where he served as managing editor of the Willamette Law Review.

J. Christopher Naftzger
Chief Legal Officer and Corporate Secretary

Jennifer Rosenberg - Senior Director of Patient Marketing
Jennifer Rosenberg is an experienced healthcare marketer with deep expertise in patient marketing. Most recently, Jennifer was Director of Patient Marketing for the Spinal Muscular Atrophy Franchise at Biogen. Prior to Biogen, she led Marketing at Insulet Corporation and held patient/consumer marketing roles at Johnson & Johnson, Abbott, and EXACT Sciences. Jennifer has a BA in Biology from Brandeis University and an MBA in Marketing from The Wharton School of the University of Pennsylvania.  Outside of work, Jennifer enjoys spending time with family, traveling, and watching her son compete in Ultimate Frisbee.

Jennifer Rosenberg
Senior Director of Patient Marketing

Jing Marantz - Board Member
Dr. Marantz has more than 20 years of experience in the biopharmaceutical industry across roles spanning development, medical affairs, business development, and commercial strategy in multiple specialties and rare diseases. She currently serves as the Senior Vice President, Head of Medical Affairs at Acceleron Pharma. Prior to joining Acceleron in 2020, Dr. Marantz was Senior Vice President, Head of Medical Affairs at Alnylam Pharmaceuticals where she built the medical affairs organization into a global footprint across 19 countries and led two successful global product launches (Onpattro and Givlaari). Prior to Alnylam, Dr. Marantz served as Vice President, Global Medical Affairs, Head of U.S. Medical Affairs and interim Head of Latin America Medical Affairs at Alexion Pharmaceuticals where she was responsible for three marketed rare disease products (Soliris, Strensig, and Kanuma). She previously held leadership positions at Biogen, ARIAD, and Millennium Pharmaceuticals across development, medical affairs, and business development.

Jing Marantz
Board Member

John Karakkal - Vice President of North American Sales and Marketing
John Karakkal has 20 years of commercial experience in the biopharmaceutical industry.  Most recently, he was head of the Gaucher & ASMD rare disease franchises at Sanofi Genzyme for the last 3 years where he was responsible for development of the U.S. commercial strategy and tactical implementation for three brands, including preparation for an upcoming launch.  Prior to his tenure at Sanofi Genzyme, John worked at Bristol-Myers Squibb for almost 17 years, in various sales, marketing and commercial leadership roles across multiple therapeutic areas.  John holds a B.S. degree in Biochemistry from Stony Brook University and an Executive MBA degree from St Joseph’s University.  When not at work, he loves spending time with his family and travelling.

John Karakkal
Vice President of North American Sales and Marketing

Jorge Guzman-Lepe
Jorge Guzman-Lepe - AS Research Associate
Jorge Guzman-Lepe (Lepe), AS Research Associate, is a MD and Pathologist, both earned in Guadalajara Mexico. Prior to joining Krystal, Lepe worked for 8 years at University of Pittsburgh in the Pathology Department, focused in Liver Research and Bioengineering, Outside of Work Lepe, likes running, watch soccer and travel.

Jorge Guzman-Lepe
AS Research Associate

Josh Suskin - Director of Human Resources and Operations
Josh Suskin is an experienced Human Resources and Operations professional with a background in pharmaceuticals and biotech as well as the food production industry.  Josh has specialized in recruiting and organizational development to help strengthen entrepreneurial cultures and set them up for success.  Josh also has experience leading continuous improvement projects across multiple departments.  Josh graduated from the University of Pittsburgh, and outside of work enjoys spending time with his family, travelling, and trying new restaurants.

Josh Suskin
Director of Human Resources and Operations

Juan Roman - Vice President Global Market Access
Juan Roman is a bi-cultural multilingual pharmaceutical professional with Global Market Access experience. Prior to joining Krystal, Juan was heading Global Market Access at Acceleron, a rare disease biotechnology company in Cambridge, MA and prior to that Juan was leading the specialty portfolio for Market Access at Abbvie. Juan has 18 years of experience in US managed markets and Global Market Access, HEOR and pricing. Juan received his B.A in Economics and International Relations from the University of Pennsylvania, and his MBA in Finance from NYU Stern School of Business. Outside of work, Juan enjoys cycling, playing basketball, and swimming.

Juan Roman
Vice President Global Market Access

Julian Gangolli - Board Member

Mr. Gangolli is President, North America of Greenwich Biosciences, a GW Pharmaceuticals PLC Company. Mr. Gangolli is responsible for building out the US commercial infrastructure and spearheading the launch of its lead therapeutic product Epidiolex®, which is indicated for the treatment of two orphan epilepsy indications, Dravet Syndrome and Lennox Gastaut Syndrome. Epidiolex launched in the US in November of 2018. Prior to joining GW Pharmaceuticals, Mr. Gangolli served as President of the North American Pharmaceutical division of Allergan, Inc. for 11 years and was a member of the Executive Committee of Allergan, where he was responsible for a 1,400-person commercial operation with sales exceeding $3.8 billion in 2014. Previously, he served as Senior Vice President, US Eye Care at Allergan, during a period in which this division launched eight new products, helping to drive growth at more than 20% annually over a five-year period. Prior to Allergan, Mr. Gangolli served as Vice President, Sales and Marketing at VIVUS, Inc., where he facilitated the successful transition of the company from a research and development start-up into a niche pharmaceutical company. Before VIVUS, Mr. Gangolli served in a number of increasingly senior marketing roles at Syntex Pharmaceuticals, Inc., and Ortho-Cilag Pharmaceuticals Ltd in the UK. Mr. Gangolli received a BSc (Honors) degree in Applied Chemistry and Business Studies from Kingston University in England.

Julian Gangolli
Board Member

Justin Miller - Process Validation Associate
Justin is a Process Validation Associate at Krystal Biotech. Prior to joining Krystal, Justin worked as a downstream process development scientist at Merck for over 4 years, where he specialized in late-stage process development of antibody therapeutics, including process characterization and control strategy establishment. While at Merck, he also developed an expertise in Quality by Design and Design of Experiments. Justin is currently pursuing a master’s degree in Applied Statistics from Penn State University part-time, where he also holds a B.S. degree in Chemical Engineering. In his free time, Justin enjoys playing golf, biking, guitar playing, watching sports, and spending time with friends and family.

Justin Miller
Process Validation Associate

Kathryn Romano
Kathryn Romano - Chief Accounting Officer
Kathryn Romano was named Chief Accounting Officer in February 2020.   Kathryn most recently held the position of Corporate Controller at CNX Resources Corporation.  Prior to joining CNX, Kathryn was the Corporate Controller of Rice Energy from January 2013 until the company was acquired by EQT in November 2017, staying on to assist the company through the transition until March 2018.  Prior to joining Rice Energy, Kathryn worked in a variety of accounting and auditing roles at Black Box Corporation and Deloitte.  Kathryn is a Certified Public Accountant and holds a Bachelor of Science in Accounting from Penn State University.

Kathryn Romano
Chief Accounting Officer

Katie Corridoni
Katie Corridoni - Facilities & Project Engineer
Katie Corridoni joined the Krystal Biotech team as a Facilities & Project Engineer. She holds a B.S. in Chemical Engineering from Penn State University. Previously, she worked as an associate engineer at Merck where she provided technical support and oversight to high-volume vaccine manufacturing lines. Outside of work, Katie enjoys attending concerts, practicing yoga, and spoiling her two cats.

Katie Corridoni
Facilities & Project Engineer

Kayla Gore
Kayla Gore - Technical Accounting Manager
Kayla is a Technical Accounting Manager on the Krystal team. Before joining Krystal, Kayla was a Senior Manager at PMG LLP and served a variety of clients in various different industries. During her time at KPMG, she lived and worked in Amsterdam for 2 years. Kayla is a Certified Public Accountant and holds a Bachelor of Science in Accounting from the University of Pittsburgh.

Kayla Gore
Technical Accounting Manager

Kenzie Cadman
Kenzie Cadman - Quality Control Analyst
Kenzie is a multi-talented multi-tasker who provides support to the Quality Control group for the Krystal team. Prior to joining Krystal, Kenzie worked as a Quality Control Chemist for Mylan Pharmaceuticals. She also worked for he favorite amusement park, Kennywood Park, as a Food and Beverage Operations Manager. Kenzie received her B.S. in Biology at California University of Pennsylvania. Outside of work, Kenzie likes to play with her dogs, play videogames, and swim.

Kenzie Cadman
Quality Control Analyst

Kirti Ganorkar - Board Member
Kirti Ganorkar is the Chief Executive Officer of the India Business at Sun Pharma. Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company, producing a comprehensive portfolio of products targeting a wide spectrum of chronic and acute treatments. Sun’s manufacturing capabilities span generics, branded generics, difficult-to-make technology intensive products, over-the-counter (OTC), anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates, and with 45 manufacturing sites and 2000 marketed products, they have a presence in more than 150 countries.

Kirti Ganorkar
Board Member

Krish Krishnan - Chairman and Chief Executive Officer
Krish Krishnan is an accomplished biotech executive. He was specifically involved in two successful IPOs (COO/CFO of New River Pharmaceuticals, Inc., NASDAQ: NRPH) and COO of Intrexon Corporation, Inc., NYSE:XON), approval of the blockbuster drug Vyvanse (for ADHD in 2007) and the sale of New River Pharmaceuticals, Inc. to Shire Pharmaceuticals, plc for $2.6 billion. He served as the CEO of Pinnacle Pharmaceuticals, Inc. and advanced a potential treatment for urinary tract infection from discovery to Phase II. He has served as Board member for Biotie Therapies Oyi (BTH1V:Helsinki, NASDAQ: BITI), a specialized drug development company in Finland and Thar Pharmaceuticals,Inc. prior to its sale to Grunenthal GmbH in 2017. Previously, Krish served as a Managing Principal of Suppliermarket.com (a pharmaceutical B2B marketplace) that was sold to Ariba in 2001 for $500m. Krish started his career as a Senior Engineer at E.I.Dupont de Nemours. Krish has an undergraduate degree from the Indian Institute of Technology and a graduate degree in Finance from The Wharton School at University of Pennsylvania.

Krish Krishnan
Chairman and Chief Executive Officer

Lakshmi Pillai
Lakshmi Pillai-Kastoori - Scientist, Analytical Development
Lakshmi Pillai-Kastoori is a developmental biologist by training with over 10 years of experience in human genetics and protein biology. She currently supports the Analytical Development at Krystal Biotech. She received her Ph.D. at the University of Kentucky, a Masters of Life-Sciences from the University of Mumbai, and a Bachelor of Biotechnology from Ramnarain Ruia College, India. Before joining Krystal, she worked as an R&D Scientist at LI-COR Biosciences where she supported the development of Western blotting imaging systems and novel protein detection reagents. Outside of work, Lakshmi loves baking and gardening with her family.

Lakshmi Pillai-Kastoori
Scientist, Analytical Development

Lauren Regula - Senior Scientist
Lauren Regula is a molecular biochemist with training in the fields of virology, immunology, and biophysics. She received her Ph.D in Biomedical Sciences from Albert Einstein College of Medicine, where she studied mechanisms for neutralizing both HIV-1 and Ebolavirus and structurally characterized key proteins involved in viral entry. At Krystal Biotech, she supports discovery, preclinical, and platform development. Outside of work, Lauren is a dance and music aficionado and spends her free time tap dancing, or playing guitar, ukulele, and bass!

Lauren Regula
Senior Scientist

Lindsay Richardson - Manufacturing Tech Services
Lindsay joined the Krystal Biotech team as a Manufacturing Associate Engineer. She earned a Bachelor’s degree in Chemical Engineering from Lehigh University and passed her Fundamentals of Engineering (EIT) exam. Previously, Lindsay had been in a leadership development program at Sanofi Pasteur, where she rotated through various departments and roles, including development and execution of vaccine lyophilization protocols. Most recently, Lindsay held the role of a field engineer/ supervisor for the construction of a centralized oil facility and transfer pipeline in the Kurdistan Region of Iraq. Outside of work, Lindsay will likely be hiking or playing with her German Shepherd, Apollo. .

Lindsay Richardson
Manufacturing Tech Services

Lindsey Goodwin - Quality Assurance Specialist
Lindsey has joined the Krystal team to provide support in the quality assurance department. She has worked in the biopharmaceutical industry for over 10 years and has experience in quality assurance and GMP manufacturing.  Lindsey attended Duquesne University where she earned a degree in Biology, as well as a degree in Health Science. Lindsey loves spending time with her family, especially her two young daughters. She enjoys taking them to the farm, Deep Creek Lake and shopping at Target.

Lindsey Goodwin
Quality Assurance Specialist

Marcus Agostinelli - Manufacturing Tech Services
Marcus Agostinelli is a GMP Manufacturing Associate Level III who works on upstream and downstream processes including process development, procedure writing, and direct support of the GMP facility. Previously Marcus was part of a cell culture manufacturing team at Cook Myosite Inc. Marcus received his B.S. of Science: Pre-Medical/Biology from Indiana University of Pennsylvania and is currently finishing his M.S. of Science: Biotechnology/Bioinformatics at University of Maryland University College. Outside of work Marcus enjoys exercising and relaxing with friends.

Marcus Agostinelli
Manufacturing Tech Services

Malorie Hague - Human Resources Generalist
Malorie is a Human Resources Generalist on the Krystal team. Previously, Malorie worked in Human Resources at Concordia Lutheran Ministries and as a Recruiter for InnoSource. She graduated from California University of Pennsylvania. Outside of work, Malorie enjoys spending time with family and trying local breweries and restaurants!

Malorie Hague
Human Resources Generalist

Mark O’'Malley - Senior Scientist
Mark O'Malley is a molecular virologist with over 30 years of experience developing viral vectors for gene therapy applications. Prior to joining Krystal Biotech, he was involved in the development of viral vectors, from viral genome engineering through safety evaluation in early phase clinical trials. At Krystal, Mark is critically involved in platform engineering and also supports preclinical development.After a long day in the lab, Mark enjoys nothing more than spending time with his wife and son (and our two great dogs!) taking walks or just watching old movies at home. He and his wife run a small antiques business in their spare time, so they love flea markets, garage sales, and any time they get a chance to dig around an attic for all things "old, interesting, and dusty".

Mark O’'Malley
Senior Scientist

Mary Jane Kaltreider
Mary Jane Kaltreider - Research Associate, Product Development
Mary Jane Kaltreider is a Research Associate in Product Development. Prior to joining Krystal, Mary Jane received a B.S. in Biology from La Roche University in 2017. After graduation, Mary Jane worked for the University of Pittsburgh as a research technician in the division of Pulmonary, Allergy and Critical Care Medicine (PACCM). Specifically studying chronic obstructive pulmonary disease (COPD) and fibrosis. Outside or work, Mary Jane loves to read Stephen King books along with other mysteries and thrillers as well as baking.

Mary Jane Kaltreider
Research Associate, Product Development

Melissa Limbacher - Quality Control Analyst
Melissa is a multi-talented multi-tasker who provides support to the Quality Control group for the Krystal team.  Prior to joining Krystal, Melissa worked as a Quality Control Chemist for Genus LifeSciences Inc.  Melissa received her B.S. degree in biochemistry from the Indiana University of Pennsylvania.  Outside of work, Melissa enjoys baking, reading, and running.

Melissa Limbacher
Quality Control Analyst

Mladen Yovchev
Mladen Yovchev - Senior Scientist, Product Development
Mladen Yovchev is a biomedical scientist with 15+ years’ experience in stem cell research, gene engineering, and viral vector design. Prior to joining Krystal Biotech, Mladen was a faculty member at Albert Einstein College of Medicine in New York and at the University of Pittsburgh. He received his M.Sc in Cell and Developmental Biology at Sofia University in Bulgaria and his PhD in Molecular Biology at the Bulgarian Academy of Sciences. Mladen dedicates his free time to home improvement DIY and landscaping projects.

Mladen Yovchev
Senior Scientist, Product Development

Molly Steimer
Molly Steimer - Clinical Trial Associate
Molly Steimer comes to Krystal with over 8 years of research experience. After earning her BS in Biological Neuroscience from Allegheny College, she joined the Translational Neuroscience Program at the University of Pittsburgh, studying neuropathology with a focus in molecular psychiatry. Most recently, she comes from AHN, working as an oncology clinical research coordinator. Outside of work, Molly is an active member of the Girls Hope PGH Young Leadership Board. She also enjoys exercising with her two Australian Shepherds, Cooper and Leonard, reading, and drinking wine.

Molly Steimer
Clinical Trial Associate

Natalie Konesky
Natalie Konesky - Staff Accountant
Natalie is an accountant on the Krystal team.  She graduated from Robert Morris University in 2019 with a BSBA in Accounting and a MS in Cyber Security and Information Assurance.  Previously, Natalie has interned in public accounting and has worked as a fund accountant.  Outside of work, Natalie enjoys exploring different spots around Pittsburgh, hanging out at local breweries, and she loves all dogs!

Natalie Konesky
Staff Accountant

Nate Rattner - Senior Accountant
Nate Rattner is a Senior Accountant on the Krystal team.  Prior to joining Krystal, Nate worked in public accounting as an auditor for just under 4 years and then was a Senior Accountant at Kelly Restaurant Group. Nate graduated from Washington & Jefferson College in 2015.  Outside of work, Nate enjoys golf, lacrosse, and all Pittsburgh sports teams.

Nate Rattner
Senior Accountant

Nathan Angeloff
Nathan Angeloff - Senior Clinical Trials Manager
Nathan Angeloff is a Senior Clinical Trials Manager with more than 13 years of clinical trials experience. Nathan holds a BS in Bioengineering from the University of Pittsburgh. Prior to his work at Krystal he worked on clinical trials as a Project Manager, Quality Assurance Auditor and CRA at Novum Pharmaceutical Research Services and as a Project Manager with the Microbices Trials Network within the Magee Women's Research Institute. Nathan enjoys trying new food/restaurants, sports, game nights and travel.

Nathan Angeloff
Senior Clinical Trials Manager

Nathan Lalli
Nathan Lalli - Manufacturing Associate
Nate (Nathan) Lalli is joining Krystal, as a GMP Manufacturing Associate. He obtained a B.A. in Biology from Washington and Jefferson College in 2018. He continued his education at Duquesne University, graduating in 2020 with a M.S. in Biotechnology. Nate has utilized his background in biology in several independent research studies, including Sea Turtle Conservation in Costa Rica. Outside of work, he enjoys spending his time outdoors, especially fishing and biking.

Nathan Lalli
Manufacturing Associate

Nathan Ward
Nathan Ward - Quality Assurance Associate
Nathan Ward is a Quality Assurance Associate. Prior to joining Krystal, Nathan was a student at University of Rochester, receiving a B.S. in Biomedical Engineering, focusing on Cell & Tissue Engineering. Additionally, he worked as an intern in QA in the biotech industry. Outside of work, Nathan loves to hike and volunteer with various groups.

Nathan Ward
Quality Assurance Associate

Nicholas Reitze - Associate Director, Analytical Sciences
Nicholas Reitze is the Manager, Analytical Sciences at Krystal Biotech with over 12 years of experience working in clinical laboratory environments regulated by CLIA, CAP, and NYSDOH. Nick received his B.S. in Biochemistry from Duquesne University and is a certified molecular biologist by the American Society of Clinical Pathology (ASCP). In his previous roles, Nick has developed and validated biomarkers used as companion diagnostics to cancer therapeutics using IHC, qPCR, Affymetrix microarray platforms, and Next Generation Sequencing. In his spare time, Nick enjoys visiting breweries, perfecting pizza recipes, traveling, and watching tv/film (especially science fiction).

Nicholas Reitze
Associate Director, Analytical Sciences

Nikhil Sarma
Nikhil Sarma - Senior Research Associate, Analytical Sciences
Nikhil Sarma is a molecular and cell biologist with over 4 years of experience in various academic labs and industry. He received his master’s degree in Molecular and Cell Biology from the University of Texas at Dallas. At Krystal, Nikhil is part of the analytical sciences team that provides support to the upstream and downstream process development. Prior to joining Krystal, Nikhil was working for an early stage prenatal genetic testing company. He is also trained in Indian classical music (Carnatic). In his free time, Nikhil pursues photography and takes an interest in learning Indian classical musical instruments.

Nikhil Sarma
Senior Research Associate, Analytical Sciences

Peipei Zhang - Scientist
Peipei Zhang has 15 years of clinical and research experience in the field of reconstructive surgery with a focus on the application of novel technologies for the treatment of chronic and non-healing dermatological wounds. She received her M.D. and Ph.D. at Medical School of Chinese PLA in Beijing, China, and practiced as an Attending Physician in the Burn Institute at PLA General Hospital, the largest burn center in China. She conducted basic research in skin wound healing and regeneration as research fellows at the University of Pittsburgh Medical Center and Weill Cornell Medical College successively. After a postdoc at the National Institutes of Health, researching molecular biology, cell biology and mouse models of gap junction proteins in skin, Peipei joined the team at Krystal Biotech where she is responsible for the development and execution of complex in vitro, ex vivo, and in vivo studies to support target identification and advancement of drug discovery projects. In her spare time, Peipei likes to stay with family and travel around in order to experience different cultures.

Peipei Zhang
Scientist

Quinten DiNicola - Quality Control Raw Materials Analyst
Quin (Quinten) DiNicola is a detail oriented, collaborative worker that strives to maintain quality systems in the Raw Material department. Previous to joining Krystal, Quin worked at Berkshire Sterile Manufacturing, as a raw material associate. Quin received his B.S. in biology from the University of Massachusetts, Amherst. Quin enjoys, music, running, and recreational sports outside of work.

Quinten DiNicola
Quality Control Raw Materials Analyst

Rachael Borromeo - Director, Regulatory Affairs
Rachael Borromeo has worked in the biopharmaceutical industry for over 20 years with experience in regulatory affairs, quality, manufacturing, and clinical operations. Rachael began her career at the Harvard Gene Therapy Initiative (Boston, MA) under the direction of Dr. Richard C. Mulligan. At Krystal, Rachael is focused on Regulatory CMC. She received her Master of Science in Regulatory Affairs and Quality Assurance from Temple University’s School of Pharmacy where she focused on biologics product development for the global market. She is also a graduate of Allegheny College with a Bachelor of Science in biology. Rachael loves to spend time traveling with her husband, Chuck and two children.

Rachael Borromeo
Director, Regulatory Affairs

Rebekah Byrne
Rebekah Byrne - Associate Director, Quality Assurance
Rebekah Byrne is the Quality Assurance Manager at Krystal Biotech.  Prior to joining the team at Krystal, Rebekah worked as the Quality Manager for a contract analytical laboratory that specialized in supporting foreign particulate investigations, as well as release testing, for pharmaceutical companies; in this position, she developed an interest in data integrity and risk management strategies for small companies.  In addition to 10 years of GMP experience, she is well-versed in applying and maintaining ISO9001 and ISO17025 accreditation requirements to quality management systems. Rebekah earned a BS in Biology and an MS in Forensic Science and Law at Duquesne University.  At home, Rebekah enjoys spending time with her husband, two young sons, two cats and her flock of backyard chickens.

Rebekah Byrne
Associate Director, Quality Assurance

Rekha Gyanchandani - Associate Director, Analytical Development
Rekha has over 10 years of experience in translational biomedical research. Prior to joining Krystal Biotech, Rekha was leading assay development for viral therapeutics at Western Oncolytics. Previously, as Research Instructor and Postdoctoral Associate at Magee-Womens Research Institute, her primary focus was breast cancer and key areas of research included drug resistance and biomarkers, liquid biopsy and mutation detection. She received her PhD in Molecular Pharmacology from the University of Pittsburgh, where she studied resistance mechanisms to antiangiogenic therapies in head and neck cancer. In her spare time, Rekha enjoys social work volunteering, traveling, biking, and spending time with her family.

Rekha Gyanchandani
Associate Director, Analytical Development

Ryan Daly
Ryan Daly - Manufacturing Associate
Ryan J Daly is a self-driven individual who performs and supports GMP manufacturing tasks and works to progress the company's journey toward their vision. Prior to joining Krystal, Ryan has worked in various labs, obtaining experience in multiple areas of science, including biologics manufacturing and cancer research. He obtained his B.S degree in Biochemistry from the University of Pittsburgh. Outside of work, Ryan enjoys playing videogames, playing guitar, and homebrewing.

Ryan Daly
Manufacturing Associate

S.D. Yogesha - Associate Director, Downstream Process Development

Yogesha (Yogi) works as a lead for the manufacturing team at Krystal. He received his PhD in Biotechnology from National Centre for Cell Science, Pune, India and got trained as X-ray Crystallographer during his postdoc. He has more than a decade of experience in molecular biology, biochemistry, and structural Biology. Prior to Krystal, he did Downstream Process Development at Cytovance Biologics, Oklahoma City, OK. He likes to spend his free time with family and watching his favorite sports.

S.D. Yogesha
Associate Director, Downstream Process Development

Samuel Broder, M.D. - Chairman of Scientific Advisory Board
Dr. Samuel Broder has spent a lifetime at the forefront of science and medicine in many diverse arenas. He is the former Director of the National Cancer Institute (NCI), the largest and most important Agency for cancer research in the world.  President Ronald Reagan appointed Dr. Broder to serve in this position in January, 1989, and he continued to serve in this role for six years.  He oversaw the development of numerous anti-cancer therapeutic agents. Dr. Broder also helped launch a number of large-scale clinical trials related to the prevention, diagnosis, and treatment of cancer, and he inaugurated the highly successful Specialized Program of Research Excellence (SPORE). He joined the Celera Corporation at its founding in 1998, as the Executive Vice President for Medical Affairs and Chief Medical Officer, and there he helped advance the human genome project, i.e., the elucidation of the 3 billion letters of code that make up human DNA. He has served in numerous positions in industry, including membership on a number of corporate boards and scientific advisory bodies.  His most recent executive position was as SVP, Health Sector, Intrexon Corp, with responsibilities for gene therapy and synthetic biology. Dr. Broder has spent his entire career in translational medicine, and his research interests have included the relationship between immunodeficiency disorders and cancer, medical applications of the Human Genome Project, the proteomics of cancer cells, and breaking tolerance against tumor antigens in patients with advanced cancers. In the mid-1980s, in response to the AIDS pandemic, he focused his attention on HIV-1/AIDS. At the time, it was considered virtually impossible to treat established HIV-1/AIDS successfully.  His laboratory played a major role proving that it was, in fact, possible to treat HIV-1/AIDS by developing in short order the first 3 agents approved by FDA specifically to treat the AIDS virus. These are the novel nucleosides Retrovir® (AZT), Videx® (ddI), and HIVID® (ddC) which in many ways provided a foundation for modern antiretroviral  therapy. With the onset of the Covid-19 pandemic, he is now involved in programs related to vaccine development and diagnostics against SARS-CoV-2 and related topics. He graduated from the University of Michigan Medical School in Ann Arbor in 1970. He did an internship and residency in Internal Medicine at Stanford University in Palo Alto, and then did subspecialty training in medical oncology at the National Cancer Institute in Bethesda, Maryland.  He is the author or co-author of over 340 scientific publications, and is an inventor on many patents. He has received numerous awards related to his research in cancer and AIDS.  He was elected to the National Academy of Medicine in 1993.

Samuel Broder, M.D.
Chairman of Scientific Advisory Board

Sara Artusi
Sara Artusi - Scientist, Platform Development
Sara Artusi is a scientist with experience in the field of virology, tumor virology and gene therapy. She received her M.Sc. in Pharmaceutical Chemistry and Technology and her Ph.D. in Biomedicine from the University of Padua (Italy), where she developed a novel antiviral strategy against herpes viruses. Prior to joining Krystal Biotech, Sara was involved in the engineering of optimized HSV-1 based viral vectors and development of more efficient tools for viral stock production at the University of Pittsburgh. After her postdoc, Sara joined the team at Krystal Biotech to support the discovery and platform development. In her free time, she enjoys spending time with friends, cooking or trying new restaurants in town, traveling, challenging herself with yoga and circus aerial art.

Sara Artusi
Scientist, Platform Development

Sarah Coghlan - Scientist
Sarah Coghlan is a molecular biologist and analytical chemist with over eight years of experience in translational and clinical research in diverse lab environments ranging from non-GLP to CLIA, GLP, and cGMP-compliant. At Krystal, she leads downstream process development, and provides molecular support for platform and preclinical development programs. In her spare time, Sarah enjoys playing volleyball and spending time with her greyhound, Beaker.

Sarah Coghlan
Scientist

Sarah Sewchek
Sarah Sewchek - Office Manager
Sarah Sewchek returns to her hometown to join the Krystal Biotech team after spending the last six years in New York.  Sarah's background is in event production and planning and has worked on events around the globe.  Sarah is a proud Penn Stater and received her BA in Telecommunications.  Outside of work, Sarah loves to be active, whether on the Peloton or on her real bicycle, and spend time with her husband and two cats.

Sarah Sewchek
Office Manager

Serene Forte
Serene Forte - Vice President of Medical Affairs

Serene is an accomplished scientific and clinical based leader with over 15 years of direct Medical Affairs leadership experience and a record of success blending scientific education and business acumen to drive global medical affairs, public health, and patient advocacy.

She was most recently Head of North America Medical Affairs - Gene Therapy at PTC Therapeutics where she build out the team for Medical Affairs ahead of the launch for Upstaza. Prior that she was Global Lead for Gene Therapy at PTC and Executive Director Global Gene Therapy Commercial Readiness at Sarepta Therapeutics.

Serene received her Masters in Public Health from the Bloomberg School of Public Health at Johns Hopkins in Baltimore, Maryland and earned her PhD in Virology and Immunology at the University of Massachusetts Medical School in Worcester, Massachusetts.  She completed her post-doctoral training and fellowship training at Dana-Farber Cancer Institute holding dual appointments at Dana-Farber Cancer Institute and in the Department of Medicine at Harvard Medical School in Boston, Massachusetts.

Outside of work, Serene is an avid cyclist (mountain, cross, and road riding), a bee keeper, enjoys traveling, and is learning to play the ukulele. 

Serene Forte
Vice President of Medical Affairs

Serge Shnayder - Vice President of Global Business Operations and Distribution
Serge Shnayder a commercial leader with 15 years of commercial experience at both mature and early stage pharmaceutical companies. His area of focus is Global Operations and Distribution. Prior to joining Krystal, Serge was critical in the launch of Zilretta at Flexion Therapeutics (FLXN) and before that held a similar role in launching Linzess at Ironwood Pharmaceuticals (IRWD). He holds a BA in computer science from Clark University as well as a Master’s in Public Administration from Clark. While working he also completed his MBA from Babson College. While he is not working Serge can be found spending time with his wife Kat, daughter Emilya and dog Oppie. Lots of hikes, gardening and golf when time permits.

Serge Shnayder
Vice President of Global Business Operations and Distribution

Shannon Mays
Shannon Mays - Quality Control Manager
Shannon is a multi-faceted professional with a passion for Quality and Process Improvement. She has over eighteen years of experience holding cross-functional roles in Manufacturing, Quality Control, Quality Assurance, Lab Management and Bench Science. Prior to joining Krystal, Shannon worked for the same company for over 15 years, developing a strong understanding of the challenges and benefits of being part of a start-up company that transitioned to a large corporation. Outside of work, Shannon cherishes quality time and creating memories with family and friends.

Shannon Mays
Quality Control Manager

Shaun Alexander - Quality Control Analyst
Shaun Alexander is a dedicated and driven individual who is new to the quality control team at Krystal. Previous to working at Krystal, Shaun worked for the University of Pittsburgh researching COPD and atherosclerosis as a research technician. Shaun received his B.S. degree in Biochemistry at the University of Massachusetts. In his free time, Shaun enjoys running and drawing.

Shaun Alexander
Quality Control Analyst

Stacie Oliver
Stacie Oliver - Clinical Affairs Scientist
Stacie Oliver is a cell biologist with a fierce passion for clinical development and the translation of basic science discoveries into transformative treatments. She has training in the fields of genetics, stem cells/developmental biology, and regenerative medicine. Stacie received her Ph.D. in Biological Sciences from Carnegie Mellon University, where she studied mechanisms which regulate the behavior of stem cells. She then worked as a Regulatory Scientist specializing in Clinical Affairs for the cell therapy company Cook MyoSite located in Pittsburgh, PA. At Krystal Biotech, she supports the Clinical and Regulatory teams and will jump in wherever there is a need. In her free time, Stacie is a voracious reader and enjoys hiking with her dog and following Formula 1 racing.

Stacie Oliver
Clinical Affairs Scientist

Suma Krishnan - Founder and Chief Operations Officer
Suma Krishnan has 25 years of drug development experience and has delivered on multiple gene therapy programs from discovery to the clinic as Head of Therapeutics at Intrexon Corporation (NYSE:XON). Previously, she led the discovery, development, and approval of Vyvanse (blockbuster drug to treat ADHD) as SVP, Product Development at New River Pharmaceuticals. Prior to that, Suma advanced approval of Adderall XR and Fosrenol at Shire. She began her career as a discovery scientist for Janssen Pharmaceuticals, Inc. Suma has over 20 publications and 20 issued US patents. She received her Master of Science in Organic Chemistry from Villanova University, an M.B.A. from Institute of Management and Research, and an undergraduate degree in Organic Chemistry from Ferguson University.

Suma Krishnan
Founder and Chief Operations Officer

Suresh Ramasamy - Senior Scientist
Suresh Ramasamy is a structural and synthetic biologist with 15+ years of experience in soluble and membrane protein expression, purification and structural characterization. He supports down stream processing and formulation development efforts at Krystal Biotech. He received his Ph.D in structural biology at National chemical laboratory, India. Prior to Krystal Biotech, Suresh worked as technical consultant at various biotech firms. In his free time he likes to travel, trekking and listen music.

Suresh Ramasamy
Senior Scientist

Swati Banerjee
Swati Banerjee - Research Associate
Swati Banerjee is a molecular biologist with over eight years of experience in molecular and translational research in various academic labs, from the Dept. of Pediatric Gastroenterology, Hematology/Oncology, Dermatology to Pathology. At Krystal, Swati supports the preclinical development programs. She received her master’s degree in Genetics and Molecular Biology from West Virginia University. Prior to joining Krystal, Swati was involved in investigating the effect of EGFR and Met on murine liver regeneration at the University of Pittsburgh. Swati is also a dancer and choreographer, and teaches her style of contemporary/fusion dance in a non-profit organization in Pittsburgh. In her free time, she loves to enjoy quality time with her family, watch movies, or do some knitting and crafts.

Swati Banerjee
Research Associate

Thomas Buettner
Thomas Buettner - Materials Manager
Thomas Buettner has a background within the logistics and shipping and receiving areas, the last few years working in distribution. He has over 10 years' experience in the consumer world and is excited to be a part of the growing medical industry in Western Pennsylvania. Thomas is a native Pittsburgher who enjoys the Penguins (a little too much) and the other local sports teams as well. Other than work, Thomas loves to spend the weekends relaxing and adventures with his wife and two children. In his personal time, he loves diving into a great biography or crime story.

Thomas Buettner
Materials Manager

Trevor Parry - Director, IP and Scientific Affairs
Trevor Parry manages Krystal's intellectual property portfolio, providing patent prosecution and counseling in both the US and foreign jurisdictions, as well as advising on IP management and licensing. Prior to joining Krystal, Trevor was a patent agent in Morrison & Foerster LLP's Life Sciences Group, with a focus on gene and antibody therapeutics, vaccines, and pharmaceutical manufacturing. Trevor's practice included coordinating patent prosecution and strategies in the US, Europe, Asia, and Australia. Trevor has extensive experience in patent drafting and prosecution, IP due diligence and landscape reviews, and freedom-to-operate analyses. Trevor received a B.S. in biochemistry/cell biology, as well as an M.S. in biology with an emphasis on biochemistry, from the University of California, San Diego. Trevor received his Ph.D. in molecular biology from the Department of Microbiology and Immunology at the University of California, San Francisco. His doctoral research focused on innate immunity and the interplay between bacterial pathogens and host cell signaling, incorporating work in bacterial and mammalian genetics with large-scale animal studies. In his off time, Trevor loves to travel, fly fish, and homebrew beer. Bar admission: U.S. Patent & Trademark Office

Trevor Parry
Director, IP and Scientific Affairs

Whitney Ijem
Whitney Ijem - Senior Vice President, Strategy and Business Development
Whitney Ijem is SVP, Strategy and Business Development at Krystal. Before Krystal, she was a Managing Director and Senior Biotechnology Analyst covering genetic medicine and rare disease companies at Guggenheim Securities. Prior to Joining Guggenheim, Ms. Ijem was a therapeutics analyst at Tourbillon Capital where she focused on companies across the therapeutics space. Prior to Tourbillon, she was an analyst in the J.P. Morgan Equity Research Healthcare group focused on biotechnology. Before joining J.P. Morgan, Ms. Ijem was a biotech analyst at Canaccord Genuity. She holds a B.S. in Biomedical Engineering from Washington University in St. Louis and a M.S. in Biomaterials Science from New York University.

Whitney Ijem
Senior Vice President, Strategy and Business Development